Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Jun 24 | NVAX Novavax | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,670 | 0.00 | 43,920 |
12 Jun 24 | NVAX Novavax | RSU Common Stock | Grant | Acquire A | No | No | 0 | 10,420 | 0.00 | 10,420 |
12 Jun 24 | NVAX Novavax | Stock Option Common Stock | Grant | Acquire A | No | No | 15.86 | 15,630 | 247.89 k | 15,630 |
12 Jun 24 | NVAX Novavax | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 6,670 | 0.00 | 0 |
11 Jun 24 | MXCT MaxCyte | Common Stock | Grant | Acquire A | No | No | 0 | 21,367 | 0.00 | 121,367 |
11 Jun 24 | MXCT MaxCyte | Stock Option Common Stock | Grant | Acquire A | No | No | 4.68 | 40,701 | 190.48 k | 40,701 |
4 Jun 24 | ALDX Aldeyra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.09 | 1,215 | 4.97 k | 1,215 |
4 Jun 24 | ALDX Aldeyra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.09 | 10,418 | 42.61 k | 10,418 |
4 Jun 24 | ALDX Aldeyra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.09 | 40,282 | 164.75 k | 40,282 |